Trial intelligence / Profile preview

Piroxicam and post-isometric exercises for knee osteoarthritis

IRCT20230202057310N4Phase 2Completed

Sponsor
Muhammad Institute of Medical and Allied Sciences
Start
Sep 2023
Modality
Small Molecules
Countries
1
01

Overview

Phase 2 trial of piroxicam in knee osteoarthritis (OA), sponsored by Muhammad Institute of Medical and Allied Sciences. Started Sep 2023; status: completed.

02

Drugs

piroxicam
03

Conditions

knee osteoarthritis (OA)

Beyond the preview

Go deeper on IRCT20230202057310N4.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20230202057310N4.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call